UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

American Cancer Society, American Society for Colposcopy and Cervical Pathology, and American Society for Clinical Pathology screening guidelines for the prevention and early detection of cervical cancer

CA: a cancer journal for clinicians, 2012-05, Vol.62 (3), p.147-172

2012

Volltextzugriff (PDF)

American Cancer Society, American Society for Colposcopy and Cervical Pathology, and American Society for Clinical Pathology Screening Guidelines for the Prevention and Early Detection of Cervical Cancer

American journal of clinical pathology, 2012-04, Vol.137 (4), p.516-542

2012

Volltextzugriff (PDF)

Guidelines for human papillomavirus DNA test requirements for primary cervical cancer screening in women 30 years and older

International journal of cancer, 2009-02, Vol.124 (3), p.516-520

2009

Volltextzugriff (PDF)

Human Papillomavirus Infections with Multiple Types and Risk of Cervical Neoplasia

Cancer epidemiology, biomarkers & prevention, 2006-07, Vol.15 (7), p.1274-1280

2006

Volltextzugriff (PDF)

Comparison of the Roche cobas® 4800 and Digene Hybrid Capture® 2 HPV tests for primary cervical cancer screening in the HPV FOCAL trial

BMC cancer, 2015-12, Vol.15 (1), p.968-968, Article 968

2015

Volltextzugriff (PDF)

Epidemiology of Acquisition and Clearance of Cervical Human Papillomavirus Infection in Women from a High-Risk Area for Cervical Cancer

The Journal of infectious diseases, 1999-11, Vol.180 (5), p.1415-1423

1999

Volltextzugriff (PDF)

Use of HPV testing in cervical cancer screening services in Mexico, 2008-2018: a nationwide database study

Salud pública de México, 2018-11, Vol.60 (6), p.722-733

2018

Volltextzugriff (PDF)

Randomized controlled trial of human papillomavirus testing versus Pap cytology in the primary screening for cervical cancer precursors: Design, methods and preliminary accrual results of the Canadian cervical cancer screening trial (CCCaST)

International journal of cancer, 2006-08, Vol.119 (3), p.615-623

2006

Volltextzugriff (PDF)

Dietary consumption of antioxidant nutrients and risk of incident cervical intraepithelial neoplasia

Gynecologic oncology, 2010-09, Vol.118 (3), p.289-294

2010

Volltextzugriff (PDF)

Triage strategies in cervical cancer detection in Mexico: methods of the FRIDA Study

Salud pública de México, 2016-04, Vol.58 (2), p.197-210

2016

Volltextzugriff (PDF)

Prevalence of high-risk human papilloma virus genotypes and associated risk of cervical precancerous lesions in a large U.S. screening population: Data from the ATHENA trial

Gynecologic oncology, 2015-04, Vol.137 (1), p.47-54

2015

Volltextzugriff (PDF)

A randomized controlled trial of Human Papillomavirus (HPV) testing for cervical cancer screening: trial design and preliminary results (HPV FOCAL Trial)

BMC cancer, 2010-03, Vol.10 (1), p.111-111

2010

Volltextzugriff (PDF)

Cervical cancer screening of HPV vaccinated populations: Cytology, molecular testing, both or none

Journal of clinical virology, 2016-03, Vol.76 (Suppl 1), p.S62-S68

2016

Volltextzugriff (PDF)

Human Papillomavirus (HPV) DNA Triage of Women with Atypical Squamous Cells of Undetermined Significance with cobas 4800 HPV and Hybrid Capture 2 Tests for Detection of High-Grade Lesions of the Uterine Cervix

Journal of Clinical Microbiology, 2012-04, Vol.50 (4), p.1240-1244

2012

Volltextzugriff (PDF)

Cervical cancer screening following prophylactic human papillomavirus vaccination

Vaccine, 2008-03, Vol.26, p.A16-A23

2008

Volltextzugriff (PDF)

Cervical Coinfection with Human Papillomavirus (HPV) Types as a Predictor of Acquisition and Persistence of HPV Infection

The Journal of infectious diseases, 2001-12, Vol.184 (12), p.1508-1517

2001

Volltextzugriff (PDF)

Recommendations for Implementing Human Papillomavirus-Based Cervical Cancer Screening: Lessons Learned from the HPV FOCAL Trial

Journal of obstetrics and gynaecology Canada, 2016-08, Vol.38 (8), p.723-726

2016

Volltextzugriff (PDF)

Comparison of human papillomavirus testing and cytology for cervical cancer screening in a primary health care setting in the Democratic Republic of the Congo

Gynecologic oncology, 2012-02, Vol.124 (2), p.286-291

2012

Volltextzugriff (PDF)

Introduction of molecular HPV testing as the primary technology in cervical cancer screening: Acting on evidence to change the current paradigm

Preventive medicine, 2017-05, Vol.98, p.5-14

2017

Volltextzugriff (PDF)

Human papillomavirus variants among Inuit women in northern Quebec, Canada

International journal of circumpolar health, 2015-01, Vol.74 (1), p.29482-29482

2015

Volltextzugriff (PDF)

HPV for cervical cancer screening (HPV FOCAL): Complete Round 1 results of a randomized trial comparing HPV‐based primary screening to liquid‐based cytology for cervical cancer

International journal of cancer, 2017-01, Vol.140 (2), p.440-448

2017

Volltextzugriff (PDF)

Cumulative risk of cervical intraepithelial neoplasia for women with normal cytology but positive for human papillomavirus: Systematic review and meta‐analysis

International journal of cancer, 2020-11, Vol.147 (10), p.2695-2707

2020

Volltextzugriff (PDF)

Human papillomavirus testing with Pap triage for cervical cancer prevention in Canada: a cost-effectiveness analysis

BMC medicine, 2009-11, Vol.7 (1), p.69-69, Article 69

2009

Volltextzugriff (PDF)

Population-Level Impact of the Bivalent, Quadrivalent, and Nonavalent Human Papillomavirus Vaccines: A Model―Based Analysis

JNCI : Journal of the National Cancer Institute, 2012-11, Vol.104 (22), p.1712-1723

2012

Volltextzugriff (PDF)

Efficacy of a bivalent L1 virus-like particle vaccine in prevention of infection with human papillomavirus types 16 and 18 in young women: a randomised controlled trial

The Lancet (British edition), 2004-11, Vol.364 (9447), p.1757-1765

2004

Volltextzugriff (PDF)

1 – 25 von 93

Suche als RSS-Feed

Aktive Filter

ThemaUterine Cervical Neoplasms - Virology

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(92)
Mit Volltextzugriff
(85)

Publikationsform

Artikel
(93)

Sprache

Erscheinungsjahr

n.n

Menü

Weitere Dienste

Einstellungen

American Cancer Society, American Society for Colposcopy and Cervical Pathology, and American Society for Clinical Pathology screening guidelines for the prevention and early detection of cervical cancer

American Cancer Society, American Society for Colposcopy and Cervical Pathology, and American Society for Clinical Pathology Screening Guidelines for the Prevention and Early Detection of Cervical Cancer

Guidelines for human papillomavirus DNA test requirements for primary cervical cancer screening in women 30 years and older

Human Papillomavirus Infections with Multiple Types and Risk of Cervical Neoplasia

Comparison of the Roche cobas® 4800 and Digene Hybrid Capture® 2 HPV tests for primary cervical cancer screening in the HPV FOCAL trial

Epidemiology of Acquisition and Clearance of Cervical Human Papillomavirus Infection in Women from a High-Risk Area for Cervical Cancer

Use of HPV testing in cervical cancer screening services in Mexico, 2008-2018: a nationwide database study

Randomized controlled trial of human papillomavirus testing versus Pap cytology in the primary screening for cervical cancer precursors: Design, methods and preliminary accrual results of the Canadian cervical cancer screening trial (CCCaST)

Dietary consumption of antioxidant nutrients and risk of incident cervical intraepithelial neoplasia

Triage strategies in cervical cancer detection in Mexico: methods of the FRIDA Study

Prevalence of high-risk human papilloma virus genotypes and associated risk of cervical precancerous lesions in a large U.S. screening population: Data from the ATHENA trial

A randomized controlled trial of Human Papillomavirus (HPV) testing for cervical cancer screening: trial design and preliminary results (HPV FOCAL Trial)

Cervical cancer screening of HPV vaccinated populations: Cytology, molecular testing, both or none

Human Papillomavirus (HPV) DNA Triage of Women with Atypical Squamous Cells of Undetermined Significance with cobas 4800 HPV and Hybrid Capture 2 Tests for Detection of High-Grade Lesions of the Uterine Cervix

Cervical cancer screening following prophylactic human papillomavirus vaccination

Cervical Coinfection with Human Papillomavirus (HPV) Types as a Predictor of Acquisition and Persistence of HPV Infection

Recommendations for Implementing Human Papillomavirus-Based Cervical Cancer Screening: Lessons Learned from the HPV FOCAL Trial

Comparison of human papillomavirus testing and cytology for cervical cancer screening in a primary health care setting in the Democratic Republic of the Congo

Introduction of molecular HPV testing as the primary technology in cervical cancer screening: Acting on evidence to change the current paradigm

Human papillomavirus variants among Inuit women in northern Quebec, Canada

HPV for cervical cancer screening (HPV FOCAL): Complete Round 1 results of a randomized trial comparing HPV‐based primary screening to liquid‐based cytology for cervical cancer

Cumulative risk of cervical intraepithelial neoplasia for women with normal cytology but positive for human papillomavirus: Systematic review and meta‐analysis

Human papillomavirus testing with Pap triage for cervical cancer prevention in Canada: a cost-effectiveness analysis

Population-Level Impact of the Bivalent, Quadrivalent, and Nonavalent Human Papillomavirus Vaccines: A Model―Based Analysis

Efficacy of a bivalent L1 virus-like particle vaccine in prevention of infection with human papillomavirus types 16 and 18 in young women: a randomised controlled trial

Aktive Filter

Suchergebnisse filtern